Reaction
Bradycardia Neonatal reporting signals
As of the last recalculation, Bradycardia Neonatal appears in 1,235 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is AMPICILLIN (PRR 71.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ampicillin | 34 | 71.1 | 71.4 |
| Ampicillin Sodium | 34 | 71.1 | 71.4 |
| Venlafaxine | 137 | 36.1 | 36.2 |
| Gentamicin | 21 | 27.5 | 27.6 |
| Dalteparin Sodium | 15 | 24.2 | 24.2 |
| Gentamicin Sulfate | 22 | 23.9 | 23.9 |
| Venlafaxine Hydrochloride | 146 | 21.0 | 21.0 |
| Lacosamide | 44 | 20.6 | 20.7 |
| Phenytoin | 24 | 19.7 | 19.8 |
| Misoprostol | 11 | 19.2 | 19.2 |
| Phytonadione | 9 | 18.0 | 18.0 |
| Lamotirigine | 70 | 17.4 | 17.4 |
| Lamotrigine Extended-Release | 70 | 17.4 | 17.4 |
| Lamotrigine Chewable Dispersible | 70 | 17.4 | 17.4 |
| Clobazam | 21 | 14.7 | 14.7 |
| Levetiracetam In Sodium Chloride | 62 | 14.1 | 14.2 |
| Levetiracetam Oral | 62 | 14.1 | 14.2 |
| Levetiracetam Injection | 62 | 14.1 | 14.2 |
| Levothyroxine Sodium Anhydrous | 77 | 13.7 | 13.8 |
| Citalopram Hydrobromide | 80 | 13.4 | 13.4 |
| Rocuronium Bromide | 7 | 10.1 | 10.1 |
| Levetiracetam | 71 | 9.4 | 9.4 |
| Palivizumab | 3 | 3.3 | 3.3 |